NCT04537897View on ClinicalTrials.gov

A Study in Healthy Men and Women Who Are Either Between 18 - 45 Years or Between 65 - 80 Years to Test How Different Doses of BI 474121 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

October 7, 2021

Study Completion Date

October 7, 2021

Conditions
Healthy
Interventions
DRUG

BI 474121

BI474121

DRUG

Midazolam

Midazolam

DRUG

Placebo

Placebo

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY